This is my first post on these forums and would apologies if the information that I am sharing is incomplete / naive.
While looking for options for treating Thalassemia, I came across this possible cure from FCTI / Laboratoires Dom AVMM (SUISSE) but I am not really able to really validate this information anywhere on the Web.
"
FCTI AUTOLOGOUS PRECURSOR STEM CELLS has revolutionised an improved method after twenty years of extensive research, GMP (good manufacturing practice) and clinical experience to enable physicians to treat patients with precision while not compromising on the safety aspects. FCTI stands at the threshold of ‘regenerative’ medicine where Autologous Precursor Stem Cells, manufactured via its FCTI's proprietary primary tissue culture, can potentially restore functions to injured, diseased and debilitated tissues and organs. SCT (Stem Cell Therapy) is the leading biomedical science in the rapidly emerging field of regenerative medicine.
FCTI is the world’s largest provider of its innovative Autologous Precursor Stem Cells using FCTI Proprietary procedure of primary cell tissue culture. FCTI offers Autologous Precursor Stem Cells with potent & effective results. Many years of research and experience have resulted in substantial improvements in health conditions of patients with various diseases treated with stem cells where conventional treatments and therapies have failed.
APSCT gives a choice for patients who believe that stem cell therapy can alleviate their symptoms, but are concerned about its safety issues. Since APSCT is derived from the patient’s very own blood, there is an unlikely chance of rejection or immunogenicity.
FCTI’s APSCT differs from other autologous stem cell therapies in its much detailed preparation method of primary tissue culturing. The autologous stem cells on their own are limited in their ability to differentiate into other type of cells. In FCTI, the autologous precursor stem cells are harvested using our proprietary primary tissue culturing.
FCTI’s Autologous Precursor Stem Cell Therapy (APSCT) - How is it prepared / adiministered?? 1. 5 cc of blood is required from an adult patient, while only 3 cc is drawn from a child patient.
2. There the stem cells would be further segregated from the blood cells. With FCTI’s proprietary expertise of primary cell tissue culturing, it will be made into Autologous Precursor Stem Cells, manufactured solely for a specific individual patient. These stem cells will be co-cultured with precursor stem cells using FCTI’s proprietary primary cell tissue culturing.
3. As FCTI’s APSCT are autologous adult stem cells in nature and derived from the patient’s own blood, it meets the legal medical requirement for the implantation into one’s own body.
4. Fresh Individualized Autologous Stem Cells must be implanted back to the patient
5. Progress is monitored
ADVANTAGES OF FCTI'S AUTOLOGOUS PRECURSOR STEM CELLS (with proprietary primary tissue culture) OVER OTHER ADULT STEM CELLS | FCTI's Autologous PRECURSOR Stem Cells* | Other Adult Stem Cells |
Therapeutic potential | High | Low |
Differentiation | Fast | Slow |
Adaptability | High | Low |
Cell division | Fast | Slow |
Immunogenicity | Practically nil | Higher |
Survival rate | High | Lower |
Quantity | Numerous | Less |
They are talking of Thalassemia as well as an inidication for FCTI AUTOLOGOUS PRECURSOR STEM CELLS INDIVIDUALISED THERAPY
I have taken selected excerpts from the orginal article published on their website. For further information, kindly refer: http://autologous-stemcells.com/poster&banner/big/FCTI%20APSCT.pdfWould request members of this forum to share your experience (if any) or comments on this.
Thanks!